Cargando…
Patient-reported outcomes in PROSPECT trial (Alliance N1048) – FOLFOX is not a panacea
Autores principales: | O'Cathail, Sean M., Adams, Richard, Hawkins, Maria A., Sebag-Montefiore, David, Marijnen, Corrie A.M., Fokas, Emmanouil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500448/ https://www.ncbi.nlm.nih.gov/pubmed/37720254 http://dx.doi.org/10.1016/j.ctro.2023.100672 |
Ejemplares similares
-
Challenges and Consequences of COVID-19 in the Management of Anorectal Cancer: Coming Together Through Social Distancing
por: O'Cathail, S.M., et al.
Publicado: (2020) -
A phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer (CEDAR)
por: O’Cathail, Séan M., et al.
Publicado: (2020) -
Initial Results from the Royal College of Radiologists' UK National Audit of Anal Cancer Radiotherapy 2015
por: Muirhead, R., et al.
Publicado: (2017) -
Is Thymol a Panacea?
por: Banerjee, K. P.
Publicado: (1910) -
Telemedicine Complements Effective Health-Care Delivery but Is Not a Panacea
por: Sarin, Rajiv
Publicado: (2006)